ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 303 filers reported holding ALKERMES PLC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $329,027,643 | +36.7% | 11,746,792 | +52.7% | 0.07% | +43.5% |
Q2 2023 | $240,724,107 | +27.3% | 7,690,866 | +14.6% | 0.05% | +24.3% |
Q1 2023 | $189,164,344 | +19.8% | 6,710,335 | +11.0% | 0.04% | +15.6% |
Q4 2022 | $157,939,598 | +5.2% | 6,044,378 | -10.1% | 0.03% | 0.0% |
Q3 2022 | $150,112,000 | -15.4% | 6,722,405 | +12.9% | 0.03% | -11.1% |
Q2 2022 | $177,401,000 | -41.3% | 5,955,032 | -48.1% | 0.04% | -30.8% |
Q1 2022 | $302,027,000 | +10.0% | 11,479,541 | -2.8% | 0.05% | +18.2% |
Q4 2021 | $274,659,000 | -24.6% | 11,808,222 | 0.0% | 0.04% | -29.0% |
Q3 2021 | $364,166,000 | +4.4% | 11,808,222 | -17.0% | 0.06% | +6.9% |
Q2 2021 | $348,960,000 | -9.0% | 14,231,637 | -30.7% | 0.06% | -14.7% |
Q1 2021 | $383,453,000 | -6.4% | 20,527,429 | -0.1% | 0.07% | -9.3% |
Q4 2020 | $409,731,000 | +12.7% | 20,537,899 | -6.4% | 0.08% | 0.0% |
Q3 2020 | $363,703,000 | -14.5% | 21,949,492 | +0.1% | 0.08% | -21.1% |
Q2 2020 | $425,429,000 | +34.5% | 21,923,733 | -0.0% | 0.10% | +13.1% |
Q1 2020 | $316,268,000 | -29.0% | 21,932,582 | +0.5% | 0.08% | -9.7% |
Q4 2019 | $445,307,000 | +5.1% | 21,828,756 | +0.5% | 0.09% | -3.1% |
Q3 2019 | $423,677,000 | -14.0% | 21,715,932 | -0.6% | 0.10% | -11.9% |
Q2 2019 | $492,371,000 | -36.9% | 21,844,250 | +2.1% | 0.11% | -38.4% |
Q1 2019 | $780,796,000 | +22.4% | 21,397,564 | -1.0% | 0.18% | +10.6% |
Q4 2018 | $638,054,000 | -30.5% | 21,621,617 | +0.0% | 0.16% | -17.1% |
Q3 2018 | $917,503,000 | +3.2% | 21,618,829 | +0.1% | 0.19% | -2.5% |
Q2 2018 | $888,897,000 | -27.2% | 21,596,098 | +2.4% | 0.20% | -28.3% |
Q1 2018 | $1,221,778,000 | +4.2% | 21,079,700 | -1.6% | 0.28% | +6.6% |
Q4 2017 | $1,172,734,000 | +14.1% | 21,427,622 | +6.0% | 0.26% | +9.7% |
Q3 2017 | $1,027,493,000 | -11.1% | 20,210,328 | +1.3% | 0.24% | -13.2% |
Q2 2017 | $1,156,387,000 | -1.3% | 19,948,014 | -0.4% | 0.27% | -3.5% |
Q1 2017 | $1,171,250,000 | -0.9% | 20,021,376 | -5.8% | 0.28% | -4.7% |
Q4 2016 | $1,181,901,000 | +18.5% | 21,264,875 | +0.3% | 0.30% | +18.4% |
Q3 2016 | $997,158,000 | +9.0% | 21,202,580 | +0.2% | 0.25% | +5.9% |
Q2 2016 | $914,411,000 | +26.8% | 21,157,097 | +0.3% | 0.24% | +24.2% |
Q1 2016 | $721,333,000 | -54.8% | 21,097,768 | +5.0% | 0.19% | -54.4% |
Q4 2015 | $1,595,741,000 | +30.1% | 20,102,582 | -3.9% | 0.42% | +21.9% |
Q3 2015 | $1,226,842,000 | -4.9% | 20,910,881 | +4.3% | 0.34% | +2.7% |
Q2 2015 | $1,290,485,000 | +3.4% | 20,057,260 | -2.0% | 0.33% | +3.7% |
Q1 2015 | $1,247,986,000 | +4.2% | 20,468,852 | +0.1% | 0.32% | +1.6% |
Q4 2014 | $1,197,124,000 | +36.8% | 20,442,699 | +0.1% | 0.32% | +31.1% |
Q3 2014 | $875,229,000 | -14.0% | 20,415,904 | +0.9% | 0.24% | -12.0% |
Q2 2014 | $1,017,971,000 | +14.8% | 20,225,934 | +0.6% | 0.27% | +11.4% |
Q1 2014 | $886,540,000 | +14.4% | 20,107,534 | +5.5% | 0.25% | +10.3% |
Q4 2013 | $774,814,000 | +21.3% | 19,055,918 | +0.3% | 0.22% | +11.5% |
Q3 2013 | $638,676,000 | +17.9% | 18,996,903 | +0.6% | 0.20% | +13.0% |
Q2 2013 | $541,714,000 | – | 18,888,239 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |